ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Third-line therapy"
Episode Synopsis
The Lancet HIV Editor Peter Hayward talks to Beatriz Grinsztejn (Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil) about ACTG A5288, an international, multiarm trial investigating management of second-line treatment failure
More episodes of the podcast Listen to The Lancet HIV
In conversation with... Deborah Persaud
04/11/2025
In conversation with... Jayne Ellis
01/10/2025
In conversation with... Richard Wu
01/07/2025
In conversation with... Sari Reisner
28/03/2025
In God we trust